ESR1 and breast cancer: Mutations in certain non-BRCA genes with low or intermediate levels of penetrance may also contribute to BC incidence and progression, including mutations in TP53, PTEN, ATM, ESR1, CDH1, STK11, PALB2, RAD51, and BARD1 (2, 10, 11).